The Boston Herald characterizes the present efforts of companies attempting to manipulate the biochemistry behind calorie restriction: ''this is hardly a Ponce de Leon-esque expedition. The Food and Drug Administration does not consider aging a condition that requires treatment.'' Which means that no venture capitalists will fund real longevity ...